Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
116,416,667
-
Total 13F shares
-
2,652,392
-
Share change
-
+2,066,064
-
Total reported value
-
$12,779,000
-
Price per share
-
$4.86
-
Number of holders
-
11
-
Value change
-
+$9,606,649
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q2 2021
As of 30 Jun 2021,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,652,392 shares.
The largest 10 holders included
TANG CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, EMC Capital Management, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Tower Research Capital LLC (TRC), RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and DAVENPORT & Co LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.